Cargando…

Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management

BACKGROUND: This article summarizes a EUFOREA symposium, presented during the European Rhinology Research Forum in Brussels (9–10 November 2017; https://www.rhinologyresearch.eu/) which focused on novel pathways and therapeutic approaches in allergic rhinitis (AR). MAIN BODY: AR remains under-diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachert, C., Bousquet, J., Hellings, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016145/ https://www.ncbi.nlm.nih.gov/pubmed/29983907 http://dx.doi.org/10.1186/s13601-018-0210-2

Ejemplares similares

Nasal hyperreactivity and inflammation in allergic rhinitis
por: Garrelds, I. M., et al.
Publicado: (1996)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

Identification of gaps in the current allergic rhinitis guidelines and how these can be filled
por: Bousquet, Jean, et al.
Publicado: (2015)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

Actual therapeutic management of allergic and hyperreactive nasal disorders
por: Rudack, Claudia
Publicado: (2004)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine
por: Mullol, Joaquim, et al.
Publicado: (2005)

Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis
por: Ciprandi, Giorgio, et al.
Publicado: (2004)

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
por: Fokkens, Wytske, et al.
Publicado: (2015)

Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)

Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
por: TEPETAM, Fatma Merve, et al.
Publicado: (2023)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

Deposition characteristics of a new allergic rhinitis nasal spray (MP29-02*) in an anatomical model of the human nasal cavity
por: D’Addio, Alex, et al.
Publicado: (2015)

Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma
por: Feijen, Jef, et al.
Publicado: (2020)

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
por: Che, Yanlu, et al.
Publicado: (2023)

Management of Intractable Nasal Hyperreactivity by Selective Resection of Posterior Nasal Nerve Branches
por: Takahara, Daisuke, et al.
Publicado: (2017)

The SP‐TLR axis, which locally primes the nasal mucosa, is impeded in patients with allergic rhinitis
por: Larsson, Olivia, et al.
Publicado: (2021)

Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patients
por: Callebaut, Ina, et al.
Publicado: (2020)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

Effect of Botulinum Neurotoxin A Injection into the Submucoperichondrium of the Nasal Septum in Reducing Idiopathic Non-Allergic Rhinitis and Persistent Allergic Rhinitis
por: Mozafarinia, Keramat, et al.
Publicado: (2015)

Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis
por: Martin, Alain, et al.
Publicado: (2022)

Local Nasal Specific Immunotherapy for Allergic Rhinitis
por: Passalacqua, Giovanni, et al.
Publicado: (2006)

Nasal and Exhaled Nitric Oxide in Allergic Rhinitis
por: Lee, Keon Jung, et al.
Publicado: (2012)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
por: Lourenço, Olga, et al.
Publicado: (2020)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm
por: Scadding, Glenis Kathleen, et al.
Publicado: (2021)

The relationship between nasal polyps, bronchial asthma, allergic rhinitis, atopic dermatitis, and non-allergic rhinitis
por: Wojas, Oksana, et al.
Publicado: (2021)

Fluticasone furoate nasal spray in the treatment of allergic rhinitis
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2008)

Individualized Treatment of Allergic Rhinitis According to Nasal Cytology
por: Chen, Jianjun, et al.
Publicado: (2017)

Nasal mucus proteome and its involvement in allergic rhinitis
por: Tomazic, Peter Valentin, et al.
Publicado: (2020)

The Effectiveness of Budesonide Nasal Irrigation in Patients with Allergic Rhinitis
por: Ishak, Muhammad Nu’aim, et al.
Publicado: (2022)

Clinical features and nasal inflammation in asthma and allergic rhinitis
por: Chen, Meiping, et al.
Publicado: (2022)

Management of allergic rhinitis
por: Solelhac, Geoffroy, et al.
Publicado: (2014)

Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes
por: Mitsias, Dimitrios I., et al.
Publicado: (2020)

Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China
por: Lou, Hongfei, et al.
Publicado: (2017)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mhl6cjfalkolq0l293ns5gjjoj